Abstract
Combining p38MAPK Inhibitors with a Second Targeted Agent Enhances Blockade of Inflammatory Signaling-Mediated Survival in Acute Myeloid Leukemia Cells
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have